ArticleCancer research communications2023

High In Vitro and In Vivo Activity of BI-847325, a Dual MEK/Aurora Kinase Inhibitor, in Human Solid and Hematologic Cancer Models.

Vincent Vuaroqueaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.